Skip to main content

Table 1 Patient demographics

From: Does young age influence the prognosis of colorectal cancer: a population-based analysis

 

Age group

 
 

Young (<45 years)

Intermediate (45–79 years)

Elderly (80+ years)

 
 

n = 70

n = 1459

n = 557

P value

Diagnosis year (n (%))

   

0.1349

  2004

28 (40.00)

502 (34.41)

176 (31.60)

 

  2005

26 (37.14)

451 (30.91)

194 (34.83)

 

  2006

16 (22.86)

506 (34.68)

187 (33.57)

 

Age (mean ± SD (range))

38 ± 4.82 (20-44)

66 ± 9.21 (45-79)

85 ± 4.08 (80-103)

 

Age (median (interquartile range)

39 (36-41)

67 (59-74)

84 (82-87)

<0.0001

Gender (n (%))

   

<0.0001

  Female

35 (50.00)

607 (41.60)

321 (57.63)

 

  Male

35 (50.00)

852 (58.40)

236 (42.37)

 

Site (n (%))

   

<0.0001

  Colon

51 (72.86)

912 (62.51)

413 (74.15)

 

  Rectosigmoid

2 (2.86)

144 (9.87)

56 (10.05)

 

  Rectum

17 (24.29)

403 (27.62)

88 (15.80)

 

AJCC stage (n (%))

   

<0.0001

  I

9 (12.86)

296 (20.29)

98 (17.59)

 

  II

25 (35.71)

369 (25.29)

181 (32.50)

 

  III

22 (31.43)

449 (30.77)

139 (24.96)

 

  IV

13 (18.57)

319 (21.86)

107 (19.21)

 

  Unknown/NA

1 (1.43)

26 (1.78)

32 (5.75)

 

T stage (n (%))

   

0.0267

  NA

 

1 (0.07)

  

  T0

 

1 (0.07)

2 (0.36)

 

  T1

9 (12.86)

182 (12.47)

72 (12.93)

 

  T2

6 (8.57)

191 (13.09)

55 (9.87)

 

  T3

33 (47.14)

771 (52.84)

284 (50.99)

 

  T4

20 (28.57)

234 (16.04)

84 (15.08)

 

  TX

2 (2.86)

79 (5.41)

58 (10.41)

 

  Tis

  

2 (0.36)

 

Nodes (n (%))

   

0.0058

  N0

37 (52.86)

806 (55.24)

345 (61.94)

 

  N1

19 (27.14)

397 (27.21)

123 (22.08)

 

  N2

13 (18.57)

232 (15.90)

60 (10.77)

 

  NA

 

1 (0.07)

  

  NX

1 (1.43)

23 (1.58)

29 (5.21)

 

Metastasis (n (%))

   

0.1626

  M0

56 (80.00)

1124 (77.04)

436 (78.28)

 

  M1

13 (18.57)

319 (21.86)

107 (19.21)

 

  MX

1 (1.43)

15 (1.03)

14 (2.51)

 

  NA

 

1 (0.07)

  

Grade/differential (n (%))

   

0.0038

  1 - well differentiated

2 (2.86)

87 (5.96)

35 (6.28)

 

  2 - moderately differentiated

45 (64.29)

1003 (68.75)

329 (59.07)

 

  3 - poorly differentiated

8 (11.43)

180 (12.34)

75 (13.46)

 

  4 - undifferentiated

 

4 (0.27)

4 (0.72)

 

  9 - not determined/not available

15 (21.43)

185 (12.68)

114 (20.47)

 

Residence at diagnosis (n (%))

   

0.0275

  Rural

23 (32.86)

572 (39.20)

184 (33.03)

 

  Urban

47 (67.14)

887 (60.80)

373 (66.97)

 

Distance from CancerCare (n (%))

   

0.0300

  <21 km

44 (62.86)

835 (57.23)

341 (61.22)

 

  21-100 km

11 (15.71)

254 (17.41)

71 (12.75)

 

  101-500 km

14 (20.00)

324 (22.21)

138 (24.78)

 

  501+ km

1 (1.43)

46 (3.15)

7 (1.26)

 

Charlson score (CCI) (n (%))

   

<0.0001

  CCI count =0

39 (55.71)

604 (41.40)

194 (34.83)

 

  CCI count =1

29 (41.43)

558 (38.25)

178 (31.96)

 

  CCI count >1

2 (2.86)

297 (20.36)

185 (33.21)

 

Socioeconomic status (n (%))

   

<0.0001

  1

27 (38.57)

275 (18.85)

160 (28.73)

 

  2

11 (15.71)

318 (21.80)

125 (22.44)

 

  3

9 (12.86)

323 (22.14)

105 (18.85)

 

  4

10 (14.29)

289 (19.81)

75 (13.46)

 

  5

13 (18.57)

246 (16.86)

76 (13.64)

 

  NA

 

8 (0.55)

16 (2.87)

 
  1. AJCC (American Joint Committee on Cancer); CCI (Charlson Comorbidity Index); MX (M status cannot be assessed); NA (Not Available); Tis (Carcinoma in situ); Tx (T status cannot be assessed).